Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New cancer pill tested in Early-Stage trial

NCT ID NCT05326035

Summary

This early-stage study tested a new oral drug called WJ05129 in people with advanced solid tumors that had spread or could not be removed by surgery. The main goals were to find a safe dose, see how the body processes the drug, and check for early signs it might help control the cancer. The trial was divided into parts testing the pill alone and in combination with a common chemotherapy drug.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC MALIGNANT SOLID TUMORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Cancer Institute & Hospital Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, 100021, China

Conditions

Explore the condition pages connected to this study.